KRAS care partner and advocate Chris Conneran joined an international discussion on how artificial intelligence is shaping cancer care, with a focus on patient trust and transparency.

Expanded Access Can Feel Slow When Treatment Is Urgent. Each EAP has its own criteria for who may receive the drug. If the EAP is for pancreatic cancer, that does not mean it is available for other cancers unless those cancer types are specifically included in the EAP criteria. Every day counts, why does it take so long?

Once you know your options, the next question is: Am I eligible? Here’s how doctors typically determine if a patient qualifies for a clinical trial or specific therapy—regardless of cancer type. 6 things that matter...